Type 2 diabetes. Type 2 diabetes mellitus
Conditions
Interventions
Intervention 1: The intervention group will receive elemental magnesium in the form of 250 mg magnesium oxide tablets daily for three months. Intervention 2: Control group: Taking placebo, in the form
Sponsors
Tabriz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: An adult patient with type 2 diabetes who has been diagnosed and treated for at least one year and been treated with oral medications only. The patient's HbA1c level should be between 7 to 10. The patient should be satisfied to participate in the study.
Exclusion criteria
Exclusion criteria: Injecting insulin and taking magnesium and calcium supplements, calcium channel blockers, and diuretics. Renal failure, elevated liver enzymes, inflammatory disease, chronic diarrhea, and pregnancy. Participants should not have been admitted to another clinical trial at the same time.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Insulin resistance. Timepoint: Measurement of blood factors will be done twice (one at the beginning, before the start of the intervention, and the other three months later). Method of measurement: Blood tests. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSaba Habibzadeh
Tabriz University of Medical Sciences
Outcome results
None listed